These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 12596758)
21. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency]. Dimković N Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218 [TBL] [Abstract][Full Text] [Related]
22. The association between congestive heart failure and chronic renal disease. Silverberg D; Wexler D; Blum M; Schwartz D; Iaina A Curr Opin Nephrol Hypertens; 2004 Mar; 13(2):163-70. PubMed ID: 15202610 [TBL] [Abstract][Full Text] [Related]
23. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Silverberg DS; Wexler D; Blum M; Tchebiner JZ; Sheps D; Keren G; Schwartz D; Baruch R; Yachnin T; Shaked M; Schwartz I; Steinbruch S; Iaina A Nephrol Dial Transplant; 2003 Jan; 18(1):141-6. PubMed ID: 12480972 [TBL] [Abstract][Full Text] [Related]
24. The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions. Silverberg DS; Wexler D; Iaina A; Schwartz D Clin Exp Nephrol; 2009 Apr; 13(2):101-106. PubMed ID: 18670732 [TBL] [Abstract][Full Text] [Related]
25. [Cardio-renal syndrome and anaemia]. Jakić M Acta Med Croatica; 2009 Sep; 63 Suppl 1():38-45. PubMed ID: 20232550 [TBL] [Abstract][Full Text] [Related]
26. Anemia in chronic congestive heart failure: frequency, prognosis, and treatment. Crosato M; Steinborn W; Anker SD Heart Fail Monit; 2003; 4(1):2-6. PubMed ID: 12808478 [TBL] [Abstract][Full Text] [Related]
27. [The cardio-renal anemia syndrome]. Dimković S; Dimkovic N Med Pregl; 2007; 60(7-8):357-63. PubMed ID: 17990802 [TBL] [Abstract][Full Text] [Related]
28. Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome. Palazzuoli A; Gallotta M; Iovine F; Nuti R; Silverberg DS Int J Clin Pract; 2008 Feb; 62(2):281-6. PubMed ID: 18081797 [TBL] [Abstract][Full Text] [Related]
29. Managing anemia in patients with chronic heart failure: what do we know? Sandhu A; Soman S; Hudson M; Besarab A Vasc Health Risk Manag; 2010 Apr; 6():237-52. PubMed ID: 20407631 [TBL] [Abstract][Full Text] [Related]
30. Role of iron deficiency and anemia in cardio-renal syndromes. Attanasio P; Ronco C; Anker SD; Cicoira M; von Haehling S Semin Nephrol; 2012 Jan; 32(1):57-62. PubMed ID: 22365163 [TBL] [Abstract][Full Text] [Related]
31. Outcomes of anaemia management in renal insufficiency and cardiac disease. Silverberg D Nephrol Dial Transplant; 2003 Jun; 18 Suppl 2():ii7-12. PubMed ID: 12819294 [TBL] [Abstract][Full Text] [Related]
32. Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians. Silverberg DS; Wexler D; Blum M; Schwartz D; Keren G; Sheps D; Iaina A Isr Med Assoc J; 2003 May; 5(5):337-9. PubMed ID: 12811950 [TBL] [Abstract][Full Text] [Related]
33. Anemia management in chronic heart failure: lessons learnt from chronic kidney disease. Besarab A; Soman S Kidney Blood Press Res; 2005; 28(5-6):363-71. PubMed ID: 16534232 [TBL] [Abstract][Full Text] [Related]
34. [Anemia in congestive heart failure]. Korczowska E; Pluta A Pol Arch Med Wewn; 2004 Oct; 112(4):1235-9. PubMed ID: 15773437 [No Abstract] [Full Text] [Related]
35. The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome. Silverberg DS Heart Fail Rev; 2011 Nov; 16(6):609-14. PubMed ID: 20865450 [TBL] [Abstract][Full Text] [Related]
36. Restless legs syndrome (RLS) in anemic patients with congestive heart failure and chronic renal failure: lack of effect of anemia treatment. Zilberman M; Silverberg DS; Schwartz D; Oksenberg A Int J Cardiol; 2010 Aug; 143(2):205-7. PubMed ID: 19131126 [TBL] [Abstract][Full Text] [Related]
37. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. Silverberg DS; Wexler D; Blum M; Keren G; Sheps D; Leibovitch E; Brosh D; Laniado S; Schwartz D; Yachnin T; Shapira I; Gavish D; Baruch R; Koifman B; Kaplan C; Steinbruch S; Iaina A J Am Coll Cardiol; 2000 Jun; 35(7):1737-44. PubMed ID: 10841219 [TBL] [Abstract][Full Text] [Related]
38. The importance of anemia and its correction in the management of severe congestive heart failure. Silverberg DS; Wexler D; Iaina A Eur J Heart Fail; 2002 Dec; 4(6):681-6. PubMed ID: 12453537 [TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of anemia in cardiorenal disease. Anand IS Rev Cardiovasc Med; 2005; 6 Suppl 3():S13-21. PubMed ID: 16340934 [TBL] [Abstract][Full Text] [Related]
40. The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease. Singh AK; Hertello P Nephrol Nurs J; 2005; 32(2):199-206; quiz 207-8. PubMed ID: 15889804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]